2EBLE J N, SAUTER G, EPSTEIN J I, et al. World Health Organization classification of tumours. Pathology and genetics of tumors of the urinary system and male genital organs [M]. Lyon : IARC Press ,2004 : 12-76.
3ARGANI P, LAL P, HUTCHINSON B,et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay[J]. Am J Surg Pathol, 2003, 27(6): 750-761.
4Eble J N, Sauter G, Epstein J, et al. Pathology and genetics of tumours of the urinary system and male genital organs [M]. Lyon, France: IARC, 2004 : 37-38.
5Argani P, Antonescu C R, Peter B, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma : a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents [J]. Am J Clin Pathol, 2001,159( 1 ) : 179-192.
6Ramphal R, Pappo A, Zielenska M, et al. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the MiT transcription factor family [J]. Am J Clin Pathol, 2006, 126(3) :349-364.
7Argani P, Semra O, Satish K, et al. Xp11.2 translocation renal cell carcinoma in adults : expanded clinical, pathologic, and genetic spectrum [J]. Am J Clin Pathol, 2007,31 (8) : 1149-1160.
8Argani P, Ladanyi M. Recent advances in pediatric renal neoplasia [J], Adv Anat Pathol, 2003,10(5) : 243 -260.
9Argani P, Ladanyi M. The evolving story of renal translocation carcinomas [J]. Am J Clin Pathol, 2006,126 (3) : 332-334.
10Argani P, Ladanyi M. Translocation carcinomas of the kidney [J]. Clin Lab Med, 2005,25(2) :363-378.
1Srigley JR, Delahunt B. Uncommon and recently described renal careinomas[J]. Mod Pathol, 2009,22 Suppl 2 : S2- S23.
2Argani P, Ladanyi M. Translocation carcinomas of the kidney [J]. Clin Lab Med,2005,25(2) :363-378.
3Klaassen Z, Tatem A, Burnete JO, et M. Adult Xpll trans location associated renal cell carcinoma: time to recognize[J]. Urology,2012,80(5) :965 -968.
4Komai Y, Fujiwara M, Fujii Y, et al. Adult Xpll transloca- tion renal cell carcinoma diagnosed by cytogenetics and immunohis toehemistry[J]. Clin Cancer Res,2009,15 (4):1170- 1176.
5Eble JN, Sauter G, Epstein JI, et al. Pathology and genetics tumors of the urinary system and male genital organs[M]. Lyon.- IARC Press, 2004 : 37-38.
6Clark J, Lu YJ, Sidhar SK, et al. Fusion of splicing factor genes PSF and NonO (p54 nrb) to the TFE3 gene in papillary renal cell carcinoma[J]. Oncogene, 1997,15(18) : 2233-2239.
7Argani P, Antonescu CR, Illei PB, et al. Primary renal neo- plasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included a mong renal cell carcinomas of children and adolescents[J]. Am J Pathol,2001,159(1) :179-192.
8Argani P, Antonescu CR, Couturier J, et al. PRCC TFE3 renal carcinomas: morphologic, immunohistochemical, ul trastruetural, and molecular analysis of an entity associated with the t (X; 1)(pll. 2; q21)[J]. Am J Surg Pathol,2002, 26(12) : 1553-1566.
9Argani P, Lui MY, Couturier J, et al. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t (X; 17) (pl 1. 2 - q23) [J].Oncogene, 2003,22(34) :5374-5378.
10Kuroda N, Mikami S, Pan CC, et al. Review of renal carci noma associated with Xpl 1.2 translocations/TFE3 gene fu sions with focus on pathobiological aspect[J]. Histol His topathol,2012,27(2) :133-140.
